These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 20800559)
1. Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Bayani J; Marrano P; Graham C; Zheng Y; Li L; Katsaros D; Lassus H; Butzow R; Squire JA; Diamandis EP Mol Oncol; 2011 Feb; 5(1):48-60. PubMed ID: 20800559 [TBL] [Abstract][Full Text] [Related]
2. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250 [TBL] [Abstract][Full Text] [Related]
3. Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Bayani J; Paliouras M; Planque C; Shan SJ; Graham C; Squire JA; Diamandis EP Mol Oncol; 2008 Oct; 2(3):250-60. PubMed ID: 19383346 [TBL] [Abstract][Full Text] [Related]
4. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. Harvey TJ; Hooper JD; Myers SA; Stephenson SA; Ashworth LK; Clements JA J Biol Chem; 2000 Dec; 275(48):37397-406. PubMed ID: 10969073 [TBL] [Abstract][Full Text] [Related]
5. Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease. Skirnisdottir I; Mayrhofer M; Rydåker M; Akerud H; Isaksson A BMC Cancer; 2012 Sep; 12():407. PubMed ID: 22967087 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184 [TBL] [Abstract][Full Text] [Related]
7. Parallel overexpression of seven kallikrein genes in ovarian cancer. Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843 [TBL] [Abstract][Full Text] [Related]
8. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Shih IeM; Nakayama K; Wu G; Nakayama N; Zhang J; Wang TL Mod Pathol; 2011 May; 24(5):638-45. PubMed ID: 21240255 [TBL] [Abstract][Full Text] [Related]
9. Integrated genomic characterization of the kallikrein gene locus in cancer. Girgis AH; Bui A; White NM; Yousef GM Anticancer Res; 2012 Mar; 32(3):957-63. PubMed ID: 22399617 [TBL] [Abstract][Full Text] [Related]
10. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Clements J; Hooper J; Dong Y; Harvey T Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672 [TBL] [Abstract][Full Text] [Related]
11. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma. Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108 [TBL] [Abstract][Full Text] [Related]
12. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. Yousef GM; Diamandis EP J Biol Chem; 1999 Dec; 274(53):37511-6. PubMed ID: 10608802 [TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814 [TBL] [Abstract][Full Text] [Related]
14. A computational analysis of the genetic and transcript diversity at the kallikrein locus. Lai J; An J; Srinivasan S; Clements JA; Batra J Biol Chem; 2016 Dec; 397(12):1307-1313. PubMed ID: 27289002 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. Shan SJ; Scorilas A; Katsaros D; Diamandis EP Br J Cancer; 2007 Jan; 96(2):362-72. PubMed ID: 17242704 [TBL] [Abstract][Full Text] [Related]
16. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4. Stephenson SA; Verity K; Ashworth LK; Clements JA J Biol Chem; 1999 Aug; 274(33):23210-4. PubMed ID: 10438493 [TBL] [Abstract][Full Text] [Related]
17. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. Gunn S; Yeh IT; Lytvak I; Tirtorahardjo B; Dzidic N; Zadeh S; Kim J; McCaskill C; Lim L; Gorre M; Mohammed M BMC Cancer; 2010 Jul; 10():396. PubMed ID: 20667129 [TBL] [Abstract][Full Text] [Related]
18. TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer. Zhang M; Zhuang G; Sun X; Shen Y; Wang W; Li Q; Di W Diagn Pathol; 2017 Feb; 12(1):16. PubMed ID: 28148293 [TBL] [Abstract][Full Text] [Related]
19. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197 [TBL] [Abstract][Full Text] [Related]
20. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]